AQR Capital Management LLC Purchases 17,960 Shares of Invacare Co. (NYSE:IVC)

AQR Capital Management LLC raised its position in shares of Invacare Co. (NYSE:IVC) by 40.3% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 62,550 shares of the health services provider’s stock after acquiring an additional 17,960 shares during the quarter. AQR Capital Management LLC owned approximately 0.19% of Invacare worth $325,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. Marshall Wace LLP boosted its position in shares of Invacare by 141.0% in the 1st quarter. Marshall Wace LLP now owns 973,474 shares of the health services provider’s stock worth $8,149,000 after purchasing an additional 569,509 shares in the last quarter. Alambic Investment Management L.P. boosted its position in shares of Invacare by 33.3% in the 2nd quarter. Alambic Investment Management L.P. now owns 49,368 shares of the health services provider’s stock worth $256,000 after purchasing an additional 12,330 shares in the last quarter. Acadian Asset Management LLC boosted its position in shares of Invacare by 129.4% in the 2nd quarter. Acadian Asset Management LLC now owns 362,135 shares of the health services provider’s stock worth $1,879,000 after purchasing an additional 204,264 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. boosted its position in shares of Invacare by 13.3% in the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 85,402 shares of the health services provider’s stock worth $443,000 after purchasing an additional 10,052 shares in the last quarter. Finally, Crossmark Global Holdings Inc. boosted its position in shares of Invacare by 12.5% in the 2nd quarter. Crossmark Global Holdings Inc. now owns 28,120 shares of the health services provider’s stock worth $146,000 after purchasing an additional 3,114 shares in the last quarter.

A number of analysts have recently commented on the company. Zacks Investment Research cut Invacare from a “hold” rating to a “sell” rating in a research report on Tuesday. Needham & Company LLC reissued a “buy” rating and issued a $15.00 price target on shares of Invacare in a research report on Thursday. Finally, ValuEngine raised Invacare from a “hold” rating to a “buy” rating in a research report on Wednesday, October 2nd.

Shares of IVC opened at $6.99 on Friday. The company has a quick ratio of 1.26, a current ratio of 1.90 and a debt-to-equity ratio of 0.83. The business’s 50 day moving average price is $6.46 and its 200-day moving average price is $6.15. Invacare Co. has a 52 week low of $3.05 and a 52 week high of $14.80. The stock has a market cap of $211.50 million, a P/E ratio of -5.30 and a beta of 2.05.

Invacare (NYSE:IVC) last issued its quarterly earnings results on Monday, August 5th. The health services provider reported ($0.31) EPS for the quarter, missing analysts’ consensus estimates of ($0.28) by ($0.03). Invacare had a negative return on equity of 11.26% and a negative net margin of 4.20%. The company had revenue of $235.90 million during the quarter, compared to the consensus estimate of $238.32 million. During the same period in the prior year, the firm earned ($0.41) earnings per share. The business’s revenue for the quarter was down 4.2% compared to the same quarter last year. On average, equities analysts anticipate that Invacare Co. will post -1.13 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Friday, October 11th will be issued a $0.125 dividend. This is a positive change from Invacare’s previous quarterly dividend of $0.01. This represents a $0.50 dividend on an annualized basis and a yield of 7.15%. The ex-dividend date is Thursday, October 10th. Invacare’s payout ratio is presently -3.79%.

Invacare Company Profile

Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through Europe, North America/Home Medical Equipment, Institutional Products Group, and the Asia/Pacific segments.

Recommended Story: Stop Order Uses For Individual Investors

Want to see what other hedge funds are holding IVC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invacare Co. (NYSE:IVC).

Institutional Ownership by Quarter for Invacare (NYSE:IVC)

Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with MarketBeat.com's FREE daily email newsletter.